Cell-free DNA maps COVID-19 tissue injury and risk of death and can cause tissue injury

INTRODUCTION: The clinical course of coronavirus 2019 (COVID-19) is heterogeneous, ranging from mild to severe multiorgan failure and death. In this study, we analyzed cell-free DNA (cfDNA) as a biomarker of injury to define the sources of tissue injury that contribute to such different trajectories...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:JCI Insight
Hlavní autoři: Andargie, Temesgen E., Tsuji, Naoko, Seifuddin, Fayaz, Jang, Moon Kyoo, Yuen, Peter S.T., Kong, Hyesik, Tunc, Ilker, Singh, Komudi, Charya, Ananth, Wilkins, Kenneth, Nathan, Steven, Cox, Andrea, Pirooznia, Mehdi, Star, Robert A., Agbor-Enoh, Sean
Médium: Artigo
Jazyk:Inglês
Vydáno: American Society for Clinical Investigation 2021
Témata:
Clinical Medicine
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC8119224/
https://ncbi.nlm.nih.gov/pubmed/33651717
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1172/jci.insight.147610
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky